Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan

By sjmartinez • January 20, 2024

Tangri N, Rastogi A, Nekeman-Nan C, Hong LS, Ozaki A, Franzén S, Sofue T. Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan. Adv Ther. 2024 Jan 19. doi: 10.1007/s12325-023-02773-x. Epub ahead of print. PMID: 38240949.

Tags: Chronic kidney disease, dapagliflozin, effectiveness, Epidemiology, Nephrology, Publications, SGLT2I

Clinical practice pattern of management of plasma cell dyscrasia for kidney transplant candidates and recipients in the United States

Boppana S, Blosser CD, Webber AB, Gupta G, Singh N, Master S, Parasuraman R, Campagnaro EL, Java A, Sprangers B, Bhasin-Chhabra B, Lum EL, Khirfan[...]

Prevalence and dynamics of HLA Donor-Specific antibodies in Simultaneous Liver-Kidney transplantation

Zhang Q, Pulido MA, Soltero S, Butler C, Lum E, Abdalla B, Kendrick E, Yabu JM, Pham PT, Bunnapradist S, Veale J, Gritsch AH, Danovitch[...]

Retinal Tear as a Sign of an IgA Nephropathy Flare: A Case Report

Luu Y, Goshtaseb RR. Retinal Tear as a Sign of an IgA Nephropathy Flare: A Case Report. Cureus. 2026 Jan 6;18(1):e100946. doi: 10.7759/cureus.100946. PMID: 41658829;[...]